Our present data demonstrate that in organ-specific autoimmune diseases such as Type 1 diabetes and EAE, G-CSF mobilized MPP exert unique regulatory properties indirectly via a major mature regulatory cell type, Foxp3+ Treg, that they not only expand in vivo but also confer stabilization and fitness for controlling inflammatory settings. This evidence concerns the gene CSF3 and type 1 diabetes mellitus.